Related Experiment Videos

[Effect of fosfidomycin on development of various infections in mice]

V D Potapov1, I V Bakhteeva, V N Borzenkov

  • 1SSC Applied Microbiology, Obolensk, Moscow Region.

Insights

Fosmidomycin, an antibiotic inhibiting isoprenoid biosynthesis, showed protective effects against tularemia, typhus, and coli-septicemia in mice. Its role in tuberculosis treatment and the involvement of free radicals in its therapeutic action require further investigation.

Area of Science:

  • Microbiology and Pharmacology
  • Biochemistry of Isoprenoid Biosynthesis

Context:

  • Fosmidomycin is known as an inhibitor of the non-mevalonate pathway.
  • It has been investigated as a potential antimalarial agent.
  • Previous studies explored its therapeutic potential in various infections.

Purpose:

  • To evaluate the protective effect of fosmidomycin against experimental bacterial infections in mice.
  • To assess the efficacy of fosmidomycin in treating chronic tuberculosis in mice.
  • To investigate the potential mechanism of action involving free radicals.

Summary:

  • Fosmidomycin demonstrated a protective effect in mice infected with tularemia, typhus, and coli-septicemia.
  • No positive effect was observed in mice with chronic tuberculosis at the tested dosage.
  • Electron spin resonance (ESR) detected long-living nitroxil free radicals in fosmidomycin solutions under oxidative conditions, suggesting their potential role in its therapeutic effects.

Impact:

  • Highlights fosmidomycin's potential as a broad-spectrum antibiotic against specific bacterial infections.
  • Indicates limitations of fosmidomycin for chronic tuberculosis treatment.
  • Suggests a novel mechanism of action for fosmidomycin involving free radical generation.

Related Concept Videos